Vestmark Advisory Solutions’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $730K | Buy |
+1,877
| New | +$730K | 0.01% | 555 |
|
2023
Q3 | – | Sell |
-7,447
| Closed | -$3.31M | – | 547 |
|
2023
Q2 | $3.31M | Buy |
7,447
+496
| +7% | +$220K | 0.13% | 210 |
|
2023
Q1 | $3.2M | Buy |
6,951
+1,078
| +18% | +$496K | 0.14% | 199 |
|
2022
Q4 | $3.01M | Sell |
5,873
-103
| -2% | -$52.8K | 0.15% | 193 |
|
2022
Q3 | $2.72M | Buy |
5,976
+1,215
| +26% | +$552K | 0.15% | 190 |
|
2022
Q2 | $2.3M | Sell |
4,761
-51
| -1% | -$24.6K | 0.13% | 208 |
|
2022
Q1 | $2.36M | Buy |
4,812
+2,976
| +162% | +$1.46M | 0.13% | 204 |
|
2021
Q4 | $851K | Buy |
1,836
+58
| +3% | +$26.9K | 0.05% | 399 |
|
2021
Q3 | $663K | Buy |
1,778
+305
| +21% | +$114K | 0.04% | 415 |
|
2021
Q2 | $562K | Buy |
1,473
+71
| +5% | +$27.1K | 0.04% | 445 |
|
2021
Q1 | $503K | Sell |
1,402
-42
| -3% | -$15.1K | 0.04% | 439 |
|
2020
Q4 | $464K | Sell |
1,444
-258
| -15% | -$82.9K | 0.05% | 373 |
|
2020
Q3 | $457K | Sell |
1,702
-215
| -11% | -$57.7K | 0.06% | 339 |
|
2020
Q2 | $504K | Buy |
1,917
+97
| +5% | +$25.5K | 0.08% | 302 |
|
2020
Q1 | $413K | Buy |
+1,820
| New | +$413K | 0.08% | 296 |
|
2019
Q4 | – | Sell |
-1,484
| Closed | -$356K | – | 336 |
|
2019
Q3 | $356K | Sell |
1,484
-77
| -5% | -$18.5K | 0.06% | 372 |
|
2019
Q2 | $441K | Buy |
1,561
+99
| +7% | +$28K | 0.08% | 308 |
|
2019
Q1 | $420K | Buy |
+1,462
| New | +$420K | 0.07% | 315 |
|